Sorin Tiberiu Alexandrescu
Overview
Explore the profile of Sorin Tiberiu Alexandrescu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grigorie T, Potlog G, Alexandrescu S
Medicina (Kaunas)
. 2025 Jan;
61(1).
PMID: 39859102
In today's world, with its continuing advancements in genetics, the identification of Lynch syndrome (LS) increasingly relies on sophisticated genetic testing techniques. Most guidelines recommend a tailored surveillance program, as...
2.
Dinu I, Mihaila M, Diculescu M, Croitoru V, Turcu-Stiolica A, Bogdan D, et al.
Medicina (Kaunas)
. 2023 Feb;
59(2).
PMID: 36837551
Colorectal cancer (CRC) is a leading cause of cancer-related mortality and morbidity worldwide. Bevacizumab was approved for the treatment of metastatic colorectal cancer (mCRC) based on favorable benefit-risk assessments from...
3.
Eftimie M, Potlog G, Alexandrescu S
Medicina (Kaunas)
. 2023 Feb;
59(2).
PMID: 36837456
The peritoneum is a common site for the dissemination of digestive malignancies, particularly gastric, colorectal, appendix, or pancreatic cancer. Other tumors such as cholangiocarcinomas, digestive neuroendocrine tumors, or gastrointestinal stromal...
4.
Minciuna C, Tudor S, Micu A, Diaconescu A, Alexandrescu S, Vasilescu C
Medicina (Kaunas)
. 2022 Dec;
58(12).
PMID: 36557004
: Gastric cancer (GC) is often diagnosed in the metastatic stage. Palliative systemic therapy is still considered the gold standard, even for patients with resectable oligometastatic disease. The aim of...
5.
Alexandrescu S, Dinu I, Diaconescu A, Micu A, Pasare E, Durdu C, et al.
Medicina (Kaunas)
. 2022 Aug;
58(8).
PMID: 36013567
Background and objectives. In colorectal cancers, the embryologic origin of the primary tumor determines important molecular dissimilarities between right-sided (RS) and left-sided (LS) carcinomas. Although important prognostic differences have been...
6.
Alexandrescu S, Zarnescu N, Diaconescu A, Tomescu D, Droc G, Hrehoret D, et al.
Healthcare (Basel)
. 2022 Aug;
10(8).
PMID: 36011230
Background: The aim of this study was to investigate the impact of postoperative complications on the long-term outcomes of patients who had undergone simultaneous resection (SR) of colorectal cancer and...
7.
Alexandrescu S, Dumitru A, Babiuc R, Costea R
Rom J Morphol Embryol
. 2022 Jan;
62(2):411-425.
PMID: 35024729
Because almost one fourth of patients with rectal adenocarcinoma (RC) achieve pathological complete response (pCR) after neoadjuvant chemoradiation therapy (CRT), having significantly higher survival rates than those without pCR, the...
8.
Alexandrescu S, Selaru F, Diaconescu A, Zlate C, Blanita D, Grigorie R, et al.
J Gastrointest Surg
. 2021 Jul;
26(1):141-149.
PMID: 34258674
Background: Recent studies suggest that lymph node ratio (LNR) has significantly better prognostic power than N-status in patients with colorectal cancer, in particular when the number of evaluated lymph nodes...
9.
Alexandrescu S, Anastase D, Grigorie R, Zlate C, Andrei S, Costea R, et al.
J Gastrointestin Liver Dis
. 2020 Dec;
29(4):561-568.
PMID: 33331352
Background And Aims: The correlations between primary tumor location (right colon cancer - RCC, left colon cancer - LCC and rectal cancer - RC) and the incidence of metastatic sites...
10.
Bacalbasa N, Alexandrescu S, Popescu I
Hepat Oncol
. 2018 Sep;
2(2):159-170.
PMID: 30190995
Traditionally, patients with metastatic breast cancer were seen as carrying a grim prognosis and therapy was based mainly on palliative chemotherapy and hormonal therapy, with surgery being considered as ineffective....